[#DIV28SUPER] Fwd: [DIVTRIO] Free stats training!

FYI

Begin forwarded message:

From: "Prinstein, Mitch" <MPrinstein@APA.ORG>

Subject: [DIVTRIO] Free stats training!

Date: May 1, 2023 at 8:39:23 AM EDT

To: DIVTRIO@LISTS.APA.ORG

Reply-To: APA Division Presidential trios communicating about divisional topics <DIVTRIO@LISTS.APA.ORG>

      External Email - Use Caution      

Last semester, APA Science offered free science training on multilevel models.

Now, two of our speakers are offering more free training!  See below and pass along!

 

Free training from experts in the field!  On May 10-12, award-winning instructors Patrick Curran and Dan Bauer will co-teach the webinar Introduction to Structural Equation Modeling through the Center for Statistical Training at no cost to participants. Balancing core concepts of the underlying statistical model with an emphasis on application and interpretation, this workshop is designed to provide participants with the knowledge and skills to thoughtfully apply a variety of SEMs to their own data. Extensive software demonstrations and syntax files are provided for R (lavaan), Mplus, and Stata. Additionally, video recordings of all lectures and software demonstrations are available for one year after the workshop. Go to https://www.centerstat.org/ for additional information and to register.

Click on this link to unsubscribe from the DIVTRIO list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list.

[#DIV28SUPER] Peter F. McManus Charitable Trust grants...

Peter F. McManus Charitable Trust, Wayne, Pennsylvania

Offers research grants to non-profit ((501)(c)(3))
organizations, for research into the causes of alcoholism or
substance abuse. Basic, clinical and social science proposals
will be considered.

The Trust expects to grant approximately $225,000 this year
and will consider proposals that request up to $75,000. Please
send brief summary proposal (2-3 pages), proposed budget, copy of
institution's (501)(c)(3) letter, and investigator's bio-sketch.
Grant moneys may not be used for tuition and no more than 10% of
amount granted may be used for indirect costs. Please include an
address for the Trust&#39;s response, which will be sent via U.S.
mail.

Please send application materials to Katharine G. Lidz, 31
Independence Place, Chesterbrook, PA 19087. Applications must be
postmarked or placed with courier service on or before Friday,
September 8, 2023. APPLICATIONS SENT VIA E-MAIL WILL NOT BE
ACCEPTED. Additional information may be requested after initial
review. Before any grant may be renewed, the grant recipient
must submit a progress report to the Trust.

If you have any questions, please contact the Trust by
telephone (610) 647-4974 or e-mail at mcmanustrust@gmail.com.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] NIDA Neuroscience Update April 19, 2023

Table of Contents

I.               CSHL Neuroscience of Addiction

II.                   Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional RFA-OD-23-015

III.                 NIDA Genetics, Epigenetics, Cross-Cutting Research Team Meeting, Tuesday May 16 through Wednesday May 17, 2023, Natcher Auditorium, NIH Campus, Bethesda, MD. https://apps1.seiservices.com/NIDA/GeneticsConsortium/Default.aspx  

 

----------------

 

I.              CSHL Neuroscience of Addiction https://meetings.cshl.edu/courses.aspx?course=C-DRUG&year=23

August 9 - 15, 2023

 

Key Dates

Application Deadline:  April 24, 2023

Arrival: August 8th by 6pm EST

Departure: August 15th around 12pm EST

The primary objective of the proposed workshop is to provide an intense dialogue of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction. Targeted to new or experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research. With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative processes fundamental to addiction, withdrawal, craving, relapse to drug use and general brain function.

A range of disciplines and topics will be represented, including:

• Noninvasive brain imaging to identify drug targets and adaptive processes
• Neuroadaptative processes at the molecular and cellular level
• Neural networks and their modulation
• Relevance of genotype to susceptibility and drug response
• Tolerance and adaptation at the cellular level
• Approaches to exploiting the daunting volume generated by neuroinformatics

Application Deadline:  April 24, 2023 click here to apply

 

------------

 

II.            Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional) RFA-OD-23-015

 

The NIH Office of Disease Prevention (ODP), NIDA, and participating Institutes, Centers, and Offices are soliciting revision applications to active NIH grants through RFA-OD-23-015, Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional). 

We encourage all eligible grantees to apply. 

This RFA is designed to help active NIH R01 grantees enhance their current smoking cessation and/or other prevention intervention studies by adding components focused on menthol cigarette smoking in populations that experience health disparities (racial and ethnic minority populations [American Indian or Alaska Native, Asian American, Black or African American, Native Hawaiian or Pacific Islander, Latino or Hispanic], less privileged socioeconomic status populations, underserved rural populations, and sexual and gender minorities).  

 

Parent awards that involve prospective testing of an intervention or intervention implementation strategy, intervention development, or pilot/feasibility testing are the most appropriate for this funding opportunity.   

 

A one-time supplement of up to $150,000 direct costs may be requested. The application due date is June 19, 2023, by 5:00 p.m. local time of the applicant organization. 

 

Refer to the full RFA in the NIH Guide (RFA-OD-23-015) for complete eligibility, application, and submission information. Please direct all inquiries to the scientific/research contacts listed in the funding opportunity

.  

 

III.         NIDA Genetics, Epigenetics, Cross-Cutting Research Team Meeting, Tuesday May 16 through Wednesday May 17, 2023, Natcher Auditorium, NIH Campus, Bethesda, MD. https://apps1.seiservices.com/NIDA/GeneticsConsortium/Default.aspx  

 

The Genetics and Epigenetics Cross-Cutting Research Team of the National Institute on Drug Abuse invites you to register for the May 16-17, 2023 NIDA Genetics and Epigenetics Cross- Cutting Research Team Meeting at Natcher Conference Center, Bldg 45 on the NIH Campus in Bethesda, MD. This is an in-person meeting.

 

There is no registration fee to attend this meeting. However, attendees are responsible for their own travel, meals, and lodging.

 

The goals of the meeting are to:

• Showcase the exciting research on the genetics and epigenetics of substance use disorders.

• Encourage collaboration among investigators with different expertise in genetics and epigenetics.

• Foster collaboration between investigators working on the genetics and    epigenetics of substance abuse disorders and HIV/AIDS investigators.

• Identify new research opportunities in the genetics and epigenetics of substance use disorders.

• Provide attendees with an opportunity to meet with NIDA program directors to discuss their ideas for grant applications and funding opportunities

 

To register: https://apps1.seiservices.com/NIDA/GeneticsConsortium/Default.aspx  

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L

 

 

 

[DIV28ANNOUNCE] DIV28 April Newsletter!

Hi all,

 

I'm excited to share our first newsletter under the leadership of our new Division President, Dr. Thomas Gould. Please be sure to check out his inaugural "From the President's Desk" letter!  

 

In this issue we also have….

• Initial details on the upcoming 2023 APA Convention from Dr. Jessica Weafer. 
• A column by Dr. Nora Volkow: "Issues of Diversity, Equity, and Inclusion"
• Profiles of our 2023 Division 28 Award Winners:     
• Dr. Adam M. Leventhal, Brady-Schuster Award
• Dr. Tory Spindle, Early Career Psychopharmacologist Award
• Dr. Austin Zamarripa, Outstanding Dissertation Award
• New Division member profiles for Kimberly Weber-Clark and Justin Verlinden

 

 

*If you are interested in writing a column on issues of diversity, equity, and inclusion or if you have training/career or other announcements that you would like included in the June/July newsletter, please email: kirsten.smith@nih.gov

 

~Kirsten (Division 28 Newsletter Editor)

 

 

 

[#DIV28SUPER] FREE Webinar on Commercialization (4/19/23, 12-1 EST)

Dear colleagues,

Please see below a free webinar (scheduled for Wed 4/19, from 12 - 1 EST) discussing how to learn more about commercialization opportunities for your work. This webinar will also introduce a new and free entrepreneurship certificate and training program sponsored by NIDA. Applications for this program  will launch in a few weeks and everyone is encouraged to apply (you don't need to have a product to apply).

Sign up below to learn more!

-Kelly

 

 

 

 

Innovations for Substance Use Disorders Executive Education Wednesday, April 19, 2023 12 - 1 p.m. Presented by Johns Hopkins Carey Business School's Executive Education Join us on Wednesday, April 19 from 12 - 1 p.m. Eastern time for an exciting webinar to learn about the newly launched Innovations for Substance Use Disorders (I4SUD) Executive Education course offered at Johns Hopkins Carey Business School. I4SUD is designed to help substance use disorder researchers move their ideas to market.   Discuss the difference between a scientific discovery and an innovation and how to develop an entrepreneurial mindset with Dr. Phil Phan and learn about our new program from Dr. Supriya Munshaw. A Q&A will follow presentations. LAST CHANCE TO REGISTER About the program Innovations for Substance Use Disorders is a newly launched Executive Education certificate program for participants to work individually or in teams to assess if their ideas and inventions can be transformed into innovations to address problems in SUDs.   The virtual program features asynchronous and synchronous online activities; a multi-day visit to Carey's Baltimore - Inner Harbor location for workshops, clinical site visits, and community building. Live sessions and virtual mentoring will occur from August 28 - October 16, 2023. The in-person visit with expert panels, community building, SUD clinic visits, and a pitch competition will take place October 17 - October 20, 2023. All participants will have their airfare, meals, and accommodations covered by the sponsoring grant. The program is open to U.S.-based participants only. Learn more about the program.   Update your email subscription preferences here.

 

Follow us on social: @JHUCarey

 

[#DIV28SUPER] NIH RFI on "Pre-Addiction"

Dear Div 28 Members,

By way of this e-mail the Exec Comm wanted to make you aware of a NIH request for information (https://grants.nih.gov/grants/guide/notice-files/NOT-DA-23-019.html) related to a recent publication that championed the idea of adopting use of the concept of "pre-addiction" for use in public health messaging related to substance use disorder.

The publication that proposed this can be found here: https://pubmed.ncbi.nlm.nih.gov/35793096/

This is an interesting idea and the RFI highlights many different important areas to consider in thinking this through.  Due to the complexity of this RFI, the Exec Committee of Division 28 has opted not to submit a response on behalf of the division, but rather encourage individual members to submit comments and ideas directly to NIH.  Division leadership will also be reviewing and commenting on draft language on the topic being drafted by APA based on input from multiple stakeholders.

Hope everyone is well and enjoying spring!

Regards,

-Ryan

________________

Ryan Vandrey, Ph.D.

Past-President

APA Division 28

http://www.apadivisions.org/division-28/index.aspx

[#DIV28SUPER] Postdoc position available

Dear Colleagues,

 

We are looking for a postdoc for our T32. Please distribute widely:

 

Postdoctoral Training in Addiction Research – UAB Department of Psychiatry

 

The UAB Center for Addiction and Pain Prevention and Intervention (CAPPI) is seeking applications for a 2 year post-doc position. The postdoctoral fellow will focus on research on tobacco and cannabis behaviors as part of a T32 in the Division of Pulmonary, Allergy and Critical Care Medicine.  This post-doc provides experience in developing a line of research on medical cannabis legalization in the Deep South that coincides with the legalization of medical cannabis in Alabama. UAB is establishing a medical cannabis treatment clinic which will provide opportunities to examine medical cannabis use for specified medical conditions as part of an academic medical center. Possible areas of research include examining medical and recreational cannabis and tobacco use on lung function and other comorbid conditions.

 

The ideal candidate will have a doctoral degree in clinical psychology, epidemiology, experimental psychology, or public health with an emphasis on substance use with a strong background in clinical research. Knowledge and training in statistics and experience/training using a statistical software (e.g., SPSS, SAS, etc.) is required. In addition, strong communication and writing skills are needed for this position. The ideal candidate would be willing to move to Birmingham for the position.

 

Responsibilities include but are not limited to

- Project management

- Supporting development of data collection tools

- Analysis of existing quantitative data

- Leading and supporting manuscript writing

- Leading and supporting grant proposal development and writing

- Mentoring undergraduate and graduate students

 

Basic Qualifications

- PhD

 

Additional Qualifications

- Experience working with persons in the criminal legal system, persons living with HIV and/or substance use is highly desirable

 

Ample opportunities for professional development, mentorship, academic and research leadership, publication, and grant development will be provided through the interdisciplinary training environment in the UAB School of Medicine and Department of Pulmonology and Department of Psychiatry.  Pilot funding to establish an independent line of research will be provided through CAPPI. The post-doc will be involved in NIH-funded research with community partners, UAB and other U.S. faculty with expertise in addiction, pulmonary function, epidemiology, biostatistics, and behavioral psychology. This opportunity involves being part of a team of interdisciplinary faculty, trainees and staff collaborating through the UAB Center for Addiction and Pain Prevention Intervention (CAPPI; https://www.uab.edu/cappi/). Additional professional development opportunities are available through the UAB Center for Clinical and Translational Sciences and Center https://www.uab.edu/ccts/.

About our Postdoc Office:

UAB is committed to the development and success of outstanding postdoctoral scientists. Here at UAB, nearly 300 postdoctoral fellows are training currently in a variety of disciplines. Competitive postdoc awards are available including internships, grant incentives, funds to enhance education and collaboration outside UAB, and teaching opportunities at local universities. There is also a Postdoc Research Day with monetary awards. The Office of Postdoctoral Education strongly encourages UAB research mentors to follow the National Research Service Award stipend level guidelines, and postdoctoral scholars qualify for health, life, and other insurances. They also have the right to participate in the university’s 403(b) program and enjoy vacation, sick leave, maternity/paternity leave, and other benefits.

 

About the University:

The University of Alabama at Birmingham (UAB) is located in Birmingham, Alabama, a region disproportionately impacted by substance use, including high rates of tobacco and cannabis use. UAB is a publicly funded institution encompassing 11 schools and spanning more than 100 city blocks in downtown Birmingham. Founded in 1969, UAB is an urban university with a major medical center, which has an annual economic impact exceeding $12 billion. Forbes lists UAB among the top 20% of all US undergraduate institutions. UAB has grown rapidly from its beginnings only 50 years ago.  In FY2022, UAB received over $715 million in grants and contracts and is ranked 28^th in the nation and 11^th among public institutions for National Institutes of Health (NIH) funding. UAB is currently listed by the Carnegie Foundation in both the highest research tier and in the "community engagement" classification, an indication of how quickly UAB translates research discoveries to benefit the community. In addition, UAB was named America’s Number 1 Best Large Employer 2021 by Forbes https://www.uab.edu/news/campus/item/11852-uab-named-america-s-no-1-best-large-employer-2021-by-forbes and Number 4 Best Employer for Diversity https://www.forbes.com/best-employers-diversity/#7c6c09159b9e. UAB School of Medicine received $100 million gift, the largest gift in history for a medical school, which aims to transform and accelerate research at UAB https://www.uab.edu/news/campus/item/12307-100-million-in-gifts-to-transform-uab-school-of-medicine.

 

UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of, race, national origin, age, genetic or family medical history, gender, faith, gender identity, and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.

For more information on Equal Opportunity and Affirmative Action at UAB, visit the UAB Office of Diversity, Equity and Inclusion or call (205) 934-8762. Or contact the office at 701 20th Street South, AB 336, Birmingham, AL 35294-0103.

 

Funding. Funding for this position is available for at least 2 years. Salaries for postdocs follow the NIH guidelines https://www.niaid.nih.gov/grants-contracts/salary-cap-stipends plus benefits and four weeks’ vacation. Applicants are eligible to apply for additional research funds and awards through internal pilot grant mechanisms.

 

Deadline: Applications will be reviewed until the position is filled. Earliest start date would be July 1, 2023.

 

Applications should be submitted as single PDF document that includes

• One-page statement of academic/research interests

• Academic CV

• Contact information for three academic references

 

Inquiries and Applications should be addressed to:

Karen Cropsey, Psy.D.

Professor, Department of Psychiatry

Director, Center for Addiction and Pain Prevention and Intervention (CAPPI)

The University of Alabama at Birmingham

kcropsey@uabmc.edu

 

Thank youm

 

Karen

 

Karen Cropsey, Psy.D.

Professor of Psychiatry and Behavioral Neurobiology

Kathy Ireland Endowed Chair for Psychiatric Research

Vice Chair for Clinical Research

Director, Center for Addiction and Pain Prevention and Intervention

University of Alabama at Birmingham

 

Physical Address:

1670 University Blvd

Volker Hall, Suite L107

Birmingham, AL 35233

 

Email: kcropsey@uab.edu

Phone: 205-975-4204

 

"Our lives begin to end the day we become silent about things that matter."

- Martin Luther King Jr.